DHT has been shown to initiate porimin-dependent oncosis through ROS-mediated mitochondrial dysfunction in both in vivo and in vitro models, indicating its potential as a therapeutic agent for NSCLC (31). Here, TMEM123 is linked to non-small cell lung carcinoma.